Showing results (241-250 of 322) with videos related to
Sort By:
Pageof 33
Journal of Medicinal Chemistry|March 25, 2021
Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A ReceptorTasia Amelia, Jacobus P D van Veldhoven, Matteo Falsini, et al.Purinergic Signalling|June 15, 2024
Exploring novel dilazep derivatives as hENT1 inhibitors and potentially covalent molecular toolsMajlen A Dilweg, Marina Gorostiola González, Martijn D de Ruiter, et al.Journal of Medicinal Chemistry|February 18, 2021
Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2Natalia V Ortiz Zacarías, Kirti K Chahal, Tereza Šimková, et al.European Journal of Medicinal Chemistry|March 9, 2019
Subtle modifications to a thieno[2,3-d]pyrimidine scaffold yield negative allosteric modulators and agonists of the dopamine D2 receptorTim J Fyfe, Barrie Kellam, Shailesh N Mistry, et al.Biochemical Pharmacology|August 7, 2024
CC chemokine receptor 2 is allosterically modulated by sodium ions and amiloride derivatives through a distinct sodium ion binding siteLisa S den Hollander, Annelien J M Zweemer, Olivier J M Béquignon, et al.Journal of Medicinal Chemistry|August 2, 2023
Development of an Affinity-Based Probe to Profile Endogenous Human Adenosine ABert L H Beerkens, Inge M Snijders, Joep Snoeck, et al.ACS Chemical Neuroscience|February 19, 2016
Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine ReceptorShailesh N Mistry, Herman Lim, Manuela Jörg, et al.Journal of Medicinal Chemistry|October 22, 2013
A structure-activity analysis of biased agonism at the dopamine D2 receptorJeremy Shonberg, Carmen Klein Herenbrink, Laura López, et al.Journal of Medicinal Chemistry|June 12, 2018
Subtle Modifications to the Indole-2-carboxamide Motif of the Negative Allosteric Modulator N-(( trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1 H)-yl)ethyl)cyclohexyl)-1 H-indole-2-carboxamide (SB269652) Yield Dramatic Changes in Pharmacological Activity at the Dopamine D2 ReceptorAnitha Kopinathan, Christopher Draper-Joyce, Monika Szabo, et al.Journal of Medicinal Chemistry|December 31, 2025
Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide ReceptorGeorge J Farmer, Julie Sanchez, Annabell Millns, et al.Pageof 33